Breathe Well Live Well
|
Asthma Drug Xolair Linked to Severe Brain, Heart Issues, Pharmaceutical …
Business Wire (press release) DALLAS–(BUSINESS WIRE)–Xolair, a drug used to treat allergic asthma in adults and children 12 years and older, has been linked to significant health issues such as mini-strokes, heart attacks and blood clots, the national law firm of Baron and Budd … |
View full post on asthma – Google News
SYS-CON Media |
GSK Expands Its Asthma and COPD Portfolio in the US
Pharmaceutical Processing GlaxoSmithKline has announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in … GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News
|
FDA approves GSK's Arnuity Ellipta to treat asthma in US
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) fluticasone furoate inhalation powder, to be sold as Arnuity Ellipta, as a daily-once corticosteroid for treatment of asthma in patients aged above twelve years in the US. |
View full post on asthma – Google News
|
AstraZeneca starts Phase III program for asthma drug tralokinumab
Pharmaceutical Business Review AstraZeneca has started the Phase III program for an investigational human monoclonal antibody tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by the company's global biologics research and … |
View full post on asthma – Google News
TheHealthSite |
Malaria Drugs Eyed As Asthma Treatment, Liver Cancer Prevention Tactic
Pharmaceutical Online (press release) Researchers from the National University of Singapore (NUS) recently discovered that two, traditional anti-malaria drugs could be used to treat asthma and prevent liver cancer. Artesunate for injection is manufactured by Guilin Pharmaceuticals and … Artesunate drug can be used to control asthma, finds NUS study Herbal-Based Anti-Malarial Drug Artesunate Also Helps Control Asthma – Study Herbal anti-malaria drug may help in controlling asthma |
View full post on asthma – Google News
|
AstraZeneca enters into $232m asthma drug deal with Synairgen
Pharmaceutical Business Review AstraZeneca has entered into a global licence agreement with Synairgen for SNG001, a new, inhaled interferon beta (IFN-beta) being developed for the treatment of respiratory tract viral infections in patients with severe asthma. AstraZeneca … |
View full post on asthma – Google News
|
FDA approves Teva's QVAR with dose counter to treat asthma
Pharmaceutical Business Review The US Food and Drug Administration (FDA) has approved the use of Teva Pharmaceutical's QVAR (beclomethasone dipropionate HFA) with a dose counter for the ongoing treatment of asthma as a preventative therapy in patients five years of age and older. |
View full post on asthma – Google News
|
Teva's DuoResp Spiromax gets positive CHMP opinion to treat asthma and COPD
Pharmaceutical Business Review DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid for the treatment of underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting … Teva's Symbicort generic backed for EU approval 10 new medicines recommended for approval in Europe |
View full post on asthma – Google News
|
New Manufacturing Method Improves Drug Delivery of Asthma Inhalers
Pharmaceutical Technology Magazine (blog) A chemical engineering team from Monash University in Australia developed a method to manufacture ultrafine particles that will improve the consistency and efficiency of drugs used in metered-dose inhalers to treat asthma, the University announced in a … |
View full post on asthma – Google News
|
No significant difference in asthma control across three approaches to adjust …
Pharmaceutical Processing A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person's asthma worsened. The methods examined in this study … |
View full post on asthma – Google News